DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models.

Volume:Pages
9(1):1915
Site
Toronto
Pubmed id
29765028
Authors

Kagoya Y, Nakatsugawa M, Saso K, Guo T, Anczurowski M, Wang CH, Butler MO, Arrowsmith CH, Hirano N

DOI
10.1038/s41467-018-04262-0
Journal
Nat Commun
Publication Date
2018-5-15
Year
2018
N Publication Date
PI authors
Arrowsmith
Validated
Y